Alan C. Herman, Chief Scientific Officer at Coherus BioSciences, Inc. (CHRS), sold 11,333 shares at $28.80 ($334K) on 2015-12-01, disclosed to the SEC on 2015-12-02.
Scheduled sale ($334k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 2,400 | $69K | 20.7% |
| 2 | $29.67 | 8,933 | $265K | 79.3% |
| Total | $29.49 avg | 11,333 | $334K | 100% |
| Filing → |
| CHRS | SELL | 2017-06-05 | $424K | — | Filing → |
| CHRS | SELL | 2017-05-03 | $227K | — | Filing → |
| CHRS | SELL | 2017-04-05 | $470K | — | Filing → |